Figure 12

Pattern of distribution of microfilaraemic patients according to mf counts in the three drug groups on day 180 post-therapy (Alb: albendazole, DEC: diethylcarbamazine citrate, Alb + DEC: albendazole + diethylcarbamazine citrate).
Pattern of distribution of microfilaraemic patients according to mf counts in the three drug groups on day 180 post-therapy (Alb: albendazole, DEC: diethylcarbamazine citrate, Alb + DEC: albendazole + diethylcarbamazine citrate).